Economic evaluation of health interventions in low income settings
- INTH 306, Health Economics, Centre for International Health. Facilitator and main lecturer for the years 2002-2005.
- INTH 316, The Health Systems, Centre for International Health. Facilitator and main lecturer for the module ”Introduction to Economic Evaluation” for the years 2006-2010.
- The global HIV epidemic and research challenges to improve prevention, support and care. Lecturing and supervision at this TropEd course at the Centre for International Health for the years 2003-2010.
- ECON 221, Health Economics, Department of Economics, UiB. Guest lecturing 2006-2009.
- Miscellaneous guest lecturing at the University of Tromsø, the Univsersity College of Oslo and Norwegian Teacher Academy 2006 – 2010.
- Muhimbili University of Health and Allied Sciences: Teaching at Financing and Health Economics module in Master of Arts in Health Policy and Management, 2008.
- 2014. The role of evidence in the decision-making process of selecting essential medicines in developing countries: the cCase of Tanzania. PLoS ONE. 9. 10 pages. doi: 10.1371/journal.pone.0084824
- 2014. Economic cost of primary prevention of cardiovascular diseases in Tanzania. Health Policy and Planning. 1-10. doi: 10.1093/heapol/czu088
- 2014. Costs of promoting exclusive breastfeeding at community level in three sites in South Africa. PLoS ONE. 9. 9 pages. doi: 10.1371/journal.pone.0079784
- 2013. Infant feeding survival and Markov transition probabilities among children under age 6 months in Uganda. American Journal of Epidemiology. 177: 453-462. doi: 10.1093/aje/kws254
- 2013. Role of pharmacoeconomics in developing countries. Farmeconomia. Health economics and therapeutic pathways. 14: 3-5.
- 2013. Fagkritikkens utfordringer. Tidsskrift for Den norske legeforening. 133: 499. doi: 10.4045/tidsskr.13.0174
- 2013. Response to "Reply to: Economic evaluation of second generation pneumococcal conjugate vaccines in Norway". Vaccine. 31: 442-443. doi: 10.1016/j.vaccine.2012.11.050
- 2013. Styrer budsjettkonsekvens norske refusjonsprioriteringar? Tidsskrift for Den norske legeforening. 133: 1841-1843. doi: 10.4045/tidsskr.13.0215
- 2012. Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review. BMC Medical Informatics and Decision Making. 12:110. 9 pages. doi: 10.1186/1472-6947-12-110
- 2011. Cost of individual peer counselling for the promotion of exclusive breastfeeding in Uganda. Cost Effectiveness and Resource Allocation. 9. 9 pages. doi: 10.1186/1478-7547-9-11
- 2011. Explaining household socio-economic related child health inequalities using multiple methods in three diverse settings in South Africa. International Journal for Equity in Health. 10. 14 pages. doi: 10.1186/1475-9276-10-13
- 2011. Economic evaluation of second generation pneumococcal vaccines in Norway. Vaccine. 29: 8564-8574. doi: 10.1016/j.vaccine.2011.09.025
- 2011. Incorporating concerns for equal lifetime health in evaluations of public health programs. Social Science and Medicine. 72: 1711-1716. doi: 10.1016/j.socscimed.2011.03.032
- 2010. Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy. AIDS research and therapy. 7. doi: 10.1186/1742-6405-7-3
- 2010. Preventing Mother to Child Transmission of HIV With Highly Active Antiretroviral Treatment in Tanzania-a Prospective Cost-Effectiveness Study. Journal of Acquired Immune Deficiency Syndromes. 55: 397-403. doi: 10.1097/QAI.0b013e3181eef4d3
- 2010. The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study. Cost Effectiveness and Resource Allocation. 8. doi: 10.1186/1478-7547-8-5
- 2009. Cost estimates of HIV care and treatment with and without anti-retrovira thereapy at Arba Minch Hospital in southern Ethiopia. Cost Effectiveness and Resource Allocation. 7. doi: 10.1186/1478-7547-7-6
- 2009. Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia. Cost Effectiveness and Resource Allocation. 7. doi: 10.1186/1478-7547-7-13
- 2009. Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia. Cost Effectiveness and Resource Allocation. 7. doi: 10.1186/1478-7547-7-16
- 2007. Time preferences for health in northern Tanzania - An empirical analysis of alternative discounting models. PharmacoEconomics (Auckland). 25: 73-88.
- 2007. Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country - the case of Tanzania. Cost Effectiveness and Resource Allocation. 5. Published 2007-02-22. doi: 10.1186/1478-7547-5-3
- 2005. Estimation of private and social time preferences for health in northern Tanzania. Social Science and Medicine. 61: 1597-1607.
- 2005. QALYs vs DALYs vs LYs gained. Norsk Epidemiologi. 15: 183-191.
- 2005. QALYs vs DALYs vs LYs gained: What are the differences, and what difference do they make for health care priority setting. Norsk Epidemiologi. 15: 183-191.
- 2005. Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania. Cost Effectiveness and Resource Allocation. 3. 9 pages. doi: 10.1186/1478-7547-3-6
- 2004. Cost-effectiveness of zinc as adjunct therapy for acute childhood diarrhoea in developing countries. Bulletin of the World Health Organization. 87: 523-531.
- 2003. The relationship between prevention of mother to child transmission of HIV and stakeholder decision making in Uganda: Implications for health policy. Health Policy. 66: 199-211.
- 2005. Economic evaluation of health interventions in sub-Saharan Africa : applied economic evaluations and studies on time preferences for health in Tanzania. University of Bergen, Bergen.
- 2004. Estimation of Private and Social Time Preferences for Health in Northern Tanzania. Program for Helseøkonomi i Bergen, UiB, Bergen. 38 pages.
- 2004. Cost-effectiveness of Medical Interventions to Prevent Cardiovascular Disease in a sub-Saharan African Country - the case of Tanzania. Program for Helseøkonomi i Bergen, Bergen. 46 pages.
- 2013. The Measurement Plan. Chapter 10, pages 197-240. In:
- 2013. Epidemiology: Principles and Practical Guidelines. Elsevier. 621 pages. ISBN: 978-94-007-5988-6.
- 2013. Statistical Modeling. Chapter 24, pages 451-490. In:
- 2013. Epidemiology: Principles and Practical Guidelines. Springer. 621 pages. ISBN: 978-94-007-5989-3.
- 2010. Economic Evaluation of Health Interventions: Tanzania Perspectives. 33, pages 547-587. In:
- 2010. Handbook of Disease Burdens and Quality of Life Measures. Springer Science+Business Media B.V.. 4360 pages. ISBN: 9780387786643.
More information in national current research information system (CRIStin)
1. B Robberstad and BE Olsen. Cost-effectiveness of prevention of mother to child transmission of HIV (PMTCTplus) at Haydom Hospital in Tanzania – a prospective cost-effectiveness study. J Acquir Immune Defic Syndr. Aug 24 2010.
2. B Robberstad. and J. A. Olsen (2010). "The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study." Cost Eff Resour Alloc 8: 5 (11 p).
3. Johansson, K A, B Robberstad, et al. (2010). "Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy." AIDS Research and Therapy 7(1): 3 (9 p).
4. L Chola and B Robberstad. Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia. Cost Effectiveness and Resource Allocation, 2009, 7:16 (8p).
5. B Robberstad and Hemed Y: Economic Evaluation of Health Interventions: Tanzania Perspectives. In Handbook of Disease Burden (in press). Edited by Preedy VA. Heidelberg: Springer Verlag; 2009:547-586.
6. AD Bikilla, D Jerene, B Robberstad and B Lindtjørn. Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia. Cost Effectiveness and Resource Allocation, 2009, 7:13 (11p).
7. AD Bikilla, D Jerene, B Robberstad and B Lindtjørn. Cost estimates of HIV care and treatment with and without anti-retrovira thereapy at Arba Minch Hospital in southern Ethiopia. Cost Effectiveness and Resource Allocation, 2009, 7:6 (7p).
8. B Robberstad, Y Hemed, and OF Norheim. Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country - the case of Tanzania. Cost Effectiveness and Resource Allocation, 2007. 5: p. 3 (13p).
9. B Robberstad and J Cairns. Time preferences for health in northern Tanzania : an empirical analysis of alternative discounting models. Pharmacoeconomics, 2007. 25(1): p. 73-88.
10. B Robberstad. QALYs vs DALYs vs LYs gained: What are the differences, and what difference do they make for health care priority setting? Norwegian Epidemiology 2005; 15 (2): 183-191.
11. Wandwalo E, B Robberstad, O Morkve. Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania. Cost Effectiveness and Resource Allocation 2005;3:6.
12. B Robberstad. Estimation of private and social time preferences for health in northern Tanzania. Social Science and Medicine 2005; 61(7):1597-607.
13. B Robberstad, Strand T, Black RE, Sommerfelt H. Cost-effectiveness of zinc as adjunct therapy for acute childhood diarrhoea in developing countries. Bulletin of the World Health Organization 2004;82(7):523-31.
14. L Kapiriri, B Robberstad and OF Norheim. The Relationship between prevention of Mother to Child Transmission of HIV and Stakeholder Decision Making in Uganda: Implications for Health Policy. Health Policy, 66, 199-211, 2003.
PhD Social Economics
Title of dissertation: Economic evaluation of health interventions in sub-Saharan Africa. Applied economic evaluations and studies on time preferences for health in Tanzania. Dissertation for the PhD degree. University of Bergen 2005.
MSc Developing Economics
Title of thesis: Time Toil and Soil - Time preferences and soil conservation practices in northern Tanzania. Norwegian University of Life Sciences 1997.
1. B Robberstad, Carl Richard Frostad, Per Espen Akselsen, Kari Kværner and Aud Berstad. Economic evaluation of second generation pneumococcal conjugate vaccines in Norway. Status: Analyses complete, first draft to be finished October 2010.
2. L Chola, I Engebretsen, T Tylleskär and B Robberstad. The potential economic impact of exclusive breastfeeding on treatment costs of childhood pneumonia and diarrhoea in sub-Saharan Africa. To be submitted to Health Policy, October 2010.
3. B Robberstad and JA Olsen. Health related quality of life weights for patients living with HIV/AIDS in Tanzania. A patient survey. Status: Data collected, to be analyzed end of 2010 and manuscript prepared beginning 2011.